期刊文献+

结直肠癌中K-ras基因突变研究 被引量:3

K-ras gene mutation in colorectal cancer
暂未订购
导出
摘要 目的研究K-ras基因突变表达与结直肠癌的相关性。方法采用实时荧光定量PCR方法检测89例患者结直肠癌组织中K-ras基因2号外显子12与13编码子突变情况,并结合病理资料进行分析。结果 89例患者结直肠癌组织中K-ras基因突变者为37例,突变率为41.6%。其中12编码子突变为29例,突变率为32.6%。13编码子突变为8例,突变率为9.0%。K-ras基因突变与肿瘤位置、分化程度无明显相关性(P>0.05),与浸润深度、淋巴结转移、肝转移有相关性(P<0.05)。淋巴结转移越多K-ras基因突变率越高,有肝转移者K-ras基因突变率高。结论 K-ras基因突变在结直肠癌的发生、发展中起重要作用,与浸润深度、淋巴结转移和肝转移密切相关。 Objective To investigate the correlation between K-ras gene mutation and colorectal cancer. Methods The specimens of 89 patients with colorectal cancer were collected. K-ras mutations of exon 2 were examined by real-time fluorescence quantitative PCR at codon 12 and codon 13. The results were correspondingly analysed with clinical pathological data. Results K-ras mutations were found in 37 cases. The mutation rate was 41.6%. In 29 cases,mutations occurred in codon 12, and the mutation rate was 32.6%. Mutations occurred in codon 13 in 8 specimens with 9.0% mutation rate. No correlation between K-ras mutation and tumor location or differentiation extent was observed. The K-ras mutation rate was related to the infiltrating degree, lymph node metastasis and hepatic metastasis. Conclusion K-ras mutation plays an important role in the carcinogenesis and development of colorectal cancer,which is closely associated with invaded lymph nodes and hepatic metastasis.
出处 《实用肿瘤杂志》 CAS 2014年第1期33-35,共3页 Journal of Practical Oncology
关键词 结肠肿瘤 直肠肿瘤 K-RAS基因 突变 肿瘤转移 colonic neoplasms rectal neoplasms K-ras genes mutation neoplasm metastasis
  • 相关文献

参考文献15

  • 1Garcia M, Jemal A,Ward EM, et al. Global cancer facts and figures 2007 [ R ]. Atlanta : American Cancer Society, 2007 : 25 - 26.
  • 2孙燕.五十年来我国临床肿瘤学的发展、现状和策略[c]//中国临床肿瘤教育专辑(2009).北京:中国协和医科大学出版社,2009:1-2.
  • 3Halatsch ME, Hirsch-Ernst KI, Weinel R J, et al. Differential activation of the c-Ki-ras-2 proto-oncogene inhuman colorectal carcinoma[ J]. Anticancer Res, 1998,18 (4A):2323 - 2325.
  • 4. Zhu D,Xing D,Shen X, et al. High sensitive approach for point mutation detection based on electrochemilumine- scenee[ J]. Biosen Bioelectron ,2004,20( 3 ) .448 -453.
  • 5Dabritz J, Hanfler J, Preston R, et al. Detection of K-ras mutations in tissue and plasma samples of patients with pancreatic using PNA-mediated PCR camping and hybridization probes[ J ]. Br J Cancer, 2005,92 ( 2 ) : 405 -412.
  • 6Jhawer M, Goel S, Wilson AJ, et al. PIK3CA mutation/ PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor eetuximab [ J ]. Cancer Res, 2008,68 (6) : 1953 - 1961.
  • 7王东亮.结直肠癌中K-ras基因突变及其检测方法概述[J].实用肿瘤杂志,2011,26(6):579-583.
  • 8尹勇.K-ras基因在胰腺癌早期诊断中的研究进展[J].实用肿瘤杂志,2001,16(4):282-284. 被引量:2
  • 9袁平,孙孟红,张锦生,朱雄增.中国人大肠癌K-ras基因突变的研究[J].临床与实验病理学杂志,2000,16(6):464-466. 被引量:20
  • 10宋枫,高峰,董亮,张鑫,赵勇.p53和nm23在结直肠癌中的表达[J].西北国防医学杂志,2010,31(1):19-21. 被引量:9

二级参考文献64

  • 1王志永,刘彤华,崔全才,陈杰,赵玉沛,常欣.胰腺癌的基因诊断[J].中华病理学杂志,1994,23(5):270-273. 被引量:15
  • 2干月波,蔡心涵,郑树.结直肠癌病人粪便及组织中Ki-ras基因突变的研究[J].浙江医科大学学报,1995,24(6):241-247. 被引量:16
  • 3董强刚,黄进肃,黄建,卢丽琴,杨立民.肺癌靶向治疗研究进展与我国肺癌的EGFR基因突变概况[J].肿瘤,2005,25(6):625-628. 被引量:35
  • 4赵东兵,高纪东,单毅,周志祥,袁兴华,吴健雄,邵永孚.结肠癌根治术后转移复发的特点及预后分析[J].中华胃肠外科杂志,2006,9(4):291-293. 被引量:36
  • 5Itahana K, Dimri GP, Hara E, et al. A role for p53 in maintaining and establishing the quiescence growth arrest in human cells [ J ]. J Biol Chem, 2002,277 ( 20 ) : 18206 - 18214.
  • 6Murdoch WJ, Van Kirk EA. Steroid hormonal regulation of proliferation, p53 tumor suppressor, and apoptotic response of sheep ovarian surface epithelial cells [ J ]. Mol Cell Endocrinol,2002,186 ( 1 ) : 61 - 67.
  • 7Norberg T, Klaar S, Karl G, et al. Increased p53 mutation frequency during tumor progression - results from a breast cancer cohort [ J ]. Cancer Res,2001,61 ( 22 ) : 8317 - 8321.
  • 8Montero S, Guzman C, Vargas C, et al. Prognostic value of cytosotic p53 protein in breast cancer[ J ]. Tumor Biol,2001, 22(5) :337 -344.
  • 9Steeg PS, Cohn KH, Leone A, et al. Tumor metastasis and nm23 : current concepts [ J ]. Cancer Cells, 1991,3 ( 1 ) : 257 - 262.
  • 10[1]Kemppainer M, Raiha I, Sourander LA. marked increase in the incidence of colorectal cancer over two decades in Southwest Finland [ J ]. J Clin Epidemiol, 1997,50(2): 147

共引文献52

同被引文献35

  • 1高有义.完整结肠系膜切除在结肠癌手术治疗中的应用[J].中国药物经济学,2013,8(S1):328-329. 被引量:5
  • 2唐卫中,高枫,李卫,唐宗江.结直肠癌APC、K-ras、p53基因突变检测[J].肿瘤,2006,26(3):282-284. 被引量:16
  • 3于振香,左孟华,赵珩.胸水细胞p53和K-ras基因突变对于肺癌的诊断价值[J].中国实验诊断学,2006,10(8):857-859. 被引量:1
  • 4Garcia M, Jemal A,Ward EM, et al. Global cancer facts and figures 2007 [ R ]. Atlanta : American Cancer Society, 2007 : 25 - 26.
  • 5Dabritz J, Hanfler J, Preston R, et al. Detection of K - ras mutations in tissue and plasma samples of patients with pancreatic using PNA - me- diated PCR camping and hybridization probes [ J]. Br J Cancer,2005, 92(2) :405 -412.
  • 6Halatsch ME,Hirsch- Ernst KI, Weinel R J, et al. Differential activa- tion of the c - Ki - ras - 2 proto - oncogene in human colorectal carci- noma [ J ]. Anticancer Research, 1998, I 8 (4A) :2323 - 2325.
  • 7Zhu D, Xing D, Shen X, et al. High sensitive approach for point mu- tation detection based on electrochemiluminescence [ J]. Biosensors Bioelectronics, 2004, 20(3): 448-453.
  • 8Jhawer M, Goel S, Wilson AJ, et al. PIK3CA mutation/PTEN expres- sion status predicts response of colon cancer ceUs to the epidermal growth factor receptor inhibitor cetuximab [ J]. Cancer Res,2008,68 (6) :1953 - 1961.
  • 9Carmen JA,Milburn JJ, Mark RS, et al. American society of clinical oncology provisional clinical opinion : testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti - epidermal growth factor reerptor monoclonal antibody therapy [ J ]. J Clin Oncol. Dot : 10. 1200/JCO. 2009.21.9170.
  • 10R6nm C, Heyer J. KRAS mouse models: modeling cancer harboring KRAS mutations [ J ]. Genes & Cancer. 2011,2 ( 3 ) :335 - 343.

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部